The Clinical Laboratory Improvement Amendments (CLIA) program oversees laboratories that test human specimens for diagnostic purposes. These include hospital laboratories, stand-alone diagnostic labs, and doctors' offices.
- Laboratory Quick Start Guide for CLIA Certification
- DHHS Press Release: Initiative for More and Faster COVID-19 Testing in Nursing Homes
- CMS Laboratory Demographics Lookup
- CLIA Certification and COVID-19 Testing Memo
- Frequently Asked Questions about the CLIA Program
- CLIA Facility Status Types for Long-Term Care Facilities Memo
Contact Person: Kristen Juarez Kollu, Director of Provider Services, 803-545-4540
- CLIA SOM Chapter 6 Reference (pdf)
- Appendix C Survey Procedures for the Application of Conditions for Coverage for Independent Laboraories - Interpretive Guidelines 42 CFR 493, Subpart A-H, J, K Part 1, K Part 2, M & Q (pdf)
- Appendix Q Guidelines for Determining Immediate and Serious Threat to Patient Health and Safety